Clinical Trial Update: Anti-inflammatory Effects Glycopyrronium [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on glycopyrronium with anti-inflammatory effects in asthma and allergic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Asthma

Drugs mentioned

• glycopyrronium (glycopyrronium)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Asthma, Allergic Asthma | Phase 3 | Status: COMPLETED